The gastrointestinal tract is involved in coronavirus disease 2019 (COVID-19) caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The gut microbiota has …

There are many pharmacologic therapies that are being used or considered for treatment of
coronavirus disease 2019 (COVID-19), with rapidly changing efficacy and safety evidence …

Antibiotic resistance has become an indispensably alarming menace to the global
community. The primary factors are overuse and abuse of antibiotics, lack of novel …

Background Few small studies have described hospital-acquired infections (HAIs) occurring
in patients with COVID-19. Research Question What characteristics in critically ill patients …

Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …

Introduction The recovery of other pathogens in patients with SARS-CoV-2 infection has
been reported, either at the time of a SARS-CoV-2 infection diagnosis (co-infection) or …

Background Frequent use of antibiotics in patients with COVID-19 threatens to exacerbate
antimicrobial resistance. We aimed to establish the prevalence and predictors of bacterial …

Bacterial and fungal co-infection has been reported in patients with COVID-19, but there is
limited experience on these infections in critically ill patients. The objective of this study was …

Understanding how SARS-CoV-2 spreads within the respiratory tract is important to define
the parameters controlling the severity of COVID-19. Here we examine the functional and …

The emergence of COVID-19 infection led to the indiscriminate use of antimicrobials without
knowing their efficacy in treating the disease. The gratuitous use of antibiotics for COVID-19 …